Nanobiotix Expands Oncology Pipeline With $100M Funding
Paris, France and Cambridge, Massachusetts, USA, May 22, 2026 Nanobiotix, a late-stage clinical biotechnology company specializing in physics-based cancer...
Healthcare Investment
Advertisement
CVC and GBL Launch €10.7B Bid to Take Recordati Private
Milan, Italy, May 22, 2026 A consortium led by CVC Capital Partners IX and Groupe Bruxelles Lambert (GBL) has...
Butterfly Medical Advances Minimally Invasive BPH Technology With $21M
BOSTON and YOKNEAM, Israel, May 14, 2026 Butterfly Medical announced the successful completion of an upsized $21 million Series...
Avanos to Be Acquired by AIP in $1.27B Deal
ALPHARETTA, GEORGIA & NEW YORK, USA, April 14, 2026 Avanos Medical, Inc. has entered into a definitive agreement to...
NorthStrive Urges enVVeno to Halt Clinical Spending
NEWPORT BEACH, Calif., March 3, 2026 Investment firm NorthStrive Fund II LP has called on enVVeno Medical Corporation to...
Advertisements
BMS to Spotlight Pipeline at TD Cowen Health Meet
NEW YORK, Feb. 24, 2026 — Bristol Myers Squibb announced its participation in the upcoming TD Cowen 46th Annual...
FibroBiologics to Present at Global Healthcare Investment Forum
HOUSTON | January 6, 2026 — FibroBiologics, Inc. announced that its Founder and Chief Executive Officer will present at...
Private Equity Firm GTCR to Acquire Zentiva from Advent, Expanding Pharma Reach
Prague, Czech Republic; London, UK; Chicago, US – September 11, 2025 – Zentiva, a leading European generics pharmaceutical company,...
Advertisement
